The in vivo effect of oral administration of varying concentrations (150, 250, 500 mg/kg body wt) of sodium benzoate (a known preservative in the food, cosmetic and pharmaceutical industry) on serum liver marker enzyme activity and electrolyte levels of wistar albino rats were investigated. The oral intake was administered at 24 hour intervals for 7, 14, 21 and 28 days. The groups were labeled; control (group 1), 7days (group 2), 14days (group 3), 21 days (group 4) and 28days (group 5). The rats were fed normal diet ad libitum and blood sample for the determination was taken at the end of the duration. For serum electrolytes, the result obtained for sodium benzoate concentrations administered showed significant (p≤0.05) increase in sodium (Na+) for groups 3, 4 and 5 for 150 mg/kg body wt. and group 2, 3, 4 and 5 for 250 mg/kg body wt and 500mg/kg body wt. of experimental rats. Chloride (Cl-) showed significant (p≤0.05) increase at all administered groups for 250 mg/kg and 500mg/kg. Potassium (K+) was only significantly increased at group 5 for 500mg/kg body wt. while for bicarbonate (HCO 3 ) it showed no significant change in all treated groups. Values were all compared to the control. For liver marker enzymes, sodium benzoate Oghenetekevwe et al.; AFSJ, 11(2): 1-9, 2019; Article no.AFSJ.50650 2 significantly increased (p≤0.05) aspartate transaminase (AST) activity of experimental rats in groups 2, 3, 4 and 5 of 250 mg/kg body wt. and 500mg/kg body wt., alanine transaminase (ALT) showed significant increase (p≤0.05) in group 4 and 5 for 250 mg/kg body wt and group 2, 3, 4 and 5 for 500 mg/kg body wt., alkaline phosphatase (ALP) showed significant (p≤0.05) increase in group 2, 3, 4 and 5 for 500 mg/kg body wt.These findings suggest possible changes in blood chemistry due to the preservative.
INTRODUCTION
The investigations of constituents of blood, plasma and serum of mammals have continually played a valuable role in the normal functioning assessment of living organisms. Changes from the normal levels have been observed in disease conditions [1] . The effects of various compounds on biochemical parameters of experimental animals have been applied in assessing the safe use of compounds in products consumed. Sodium benzoate (C 6 H 5 COONa) is widely applicable as a preservative in several products consumed by man [2, 3, 4, 5] . Several studies on the short and long term effects of sodium benzoate have reported adverse effects due to both chronic and subchronic intake of sodium benzoate [6, 7] . Some reports suggest the absence of negative consequence of sodium benzoate intake [8, 9] .The upper limits of benzoate allowable in foods vary with 0.1% reported for United States of America, while a range of 0.15 to 0.25% had been reported for other countries of the world [2] . For European countries, the limit reported range is from 0.015 to 0.5% [10] . There are thus variations in the acceptable limits of these preservatives in foods. It therefore follows that sodium benzoate could be assimilated widely by consuming a wide range of food products intentionally preserved with it. The present report addressed the effects of oral administration of sodium benzoate on serum electrolyte and liver marker enzymes. The findings of this study would further assist in the interpretation of blood chemistry data for individuals who consumed foods containing the preservatives.
MATERIALS AND METHODS
The experimental analysis was carried out in the Department of Biochemistry Research Laboratory, University of Port Harcourt, Choba, Rivers State, Nigeria. The study duration was for a period of one month, twenty eight days being the longest duration. The animals were purchased from the Department of Biochemistry, Animal House. Sodium benzoate was purchased from May & Baker Ltd., England. AST and ALT Kits were purchased from Randox Laboratory, Ltd. UK, ALP Kit was purchased from TECO Diagnostic Kit, USA; while all other reagents were of analytical grade.
Animals
A total of sixty-six (66) wistar albino rats, with an average weight of 140 g were obtained from the animal house of the Department of Biochemistry, University of Port Harcourt. They were maintained on normal diet ad libitum, grouped into five (5), and housed in stainless steel cages in a well ventilated room under 12h light/dark cycle. The sodium benzoate concentrations were 150mg/kg body wt., 250 mg/kg boody wt and 500mg/kg body weight. The rats were divided into five groups namely G1 (control group), G2 (7days), G3 (14days), G4 (21days) and G5 (28days). The varying concentrations of sodium benzoate were administered orally in 1ml portions at 24 h intervals for the duration of the experiment (7, 14, 21 and 28) . At the end of the experimental duration the rats were sacrificed.
Sample Collection
The rats were anaesthetized with diethyl ether and dissected for blood collection. The blood was collected into lithium heparin bottles and analysis performed within two (2) hrs of collection. Before assays, the blood samples were centrifuged for 5 min using a bench-top centrifuge {MSE-Minor} and the supernatant was then used for the determinations.
Determination of Plasma Electrolytes
Plasma potassium concentrations followed the procedure outlined by Tietz [11] using sodium tetra-phenyl boron-formulated reagent. Sodium measurement followed the precipitation method described by Henry [12] . Chloride was measured by the titration method described by Ramnik [13] . For bicarbonate measurements, the method of Ochei and Kolhatkar [14] involving titration was used.
Determination of Serum Liver Marker Enzymes
Serum liver marker enzymes aspartate transaminase (AST) and alanine transaminase (ALT) were determined using quantitative method. The activities of ALT and AST were analysed by the end point colometric method of [15] . Alkaline phosphatase (ALP) was measured by end-point colorimetric method of [16] .
Statistical Analysis
All data were subjected to statistical analysis. The values were reported as mean ± standard error of mean (S.E.M), and analysed by one-way analysis of variance (ANOVA). ANOVA was used to test for differences between treatment groups using statistical package for social sciences (SPSS) version 20. The results were considered significant at P-values of less than 0.05, that is, at 95% confidence level (P˂0.05). 
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DISCUSSION
The elevation of aminotransferase activity in serum may be due to tissue damage particularly in liver and heart, and increased permeability of cell membrane [17] . The study revealed that rats that consumed sodium benzoate exhibited a significant (p≤0.05) increase in serum ALT, AST, and ALP activities when compared to control rats. Sodium benzoate caused derangement of liver function as revealed by significant elevation of serum ALT and AST as well as significant reduction of these enzymes in the liver. Determination of AST, ALT and ALP in the serum is largely used in the assessment of liver damage [18] . Membrane damage to the liver releases the enzymes into circulation and hence can be measured in the serum. Previous studies showed that sodium benzoate showed a significant (p≤0.05) increase in serum AST, ALT, and ALP activities and these results were attributed to hepatocellular damage which was caused by the toxic effect of sodium benzoate. It was indicated by vacuolation, swelling and necrosis of the liver cells [19] . Increase in both serum AST and ALT of rats was attributed to the changes in liver function and hepatocellular impairment which subsequently caused the release of greater than normal levels of intracellular enzymes into the blood [20] . Alkaline phosphatase occurs in the canalicular and sinusoidal membranes of the liver, thus damage to the liver will result in elevated serum ALP activity [21] . Cholestatic liver disease is characterized by an increased level of ALP. The trend of ALP significantly increase gave an indicator that the hepatic capacity of the liver is affected by sodium benzoate [21] . Also, the significant elevation of serum aminotransferases may be attributed to the fact that under pathological conditions, the parenchymal cells of hepatic lobules fail to carry out vital functions, which usually results in disturbed or imbalanced intermediatory metabolism. As a result of cellular damage, several enzymes like ALT, AST and ALP leach out into the serum and hence their level indicate the type and extent of damage inflicted [17] . Sodium benzoate caused derangement of liver function as revealed by significant elevation of serum ALT, AST and ALP. In blood plasma, sodium benzoate has a binding affinity for plasma proteins where it is carried out to different tissues. In the liver, it is metabolized by conjugation with glycine, resulting in the formation of hippuric acid [22] . Alkaline phosphatase is present on cell surfaces in most human tissues, especially those of the intestine, liver, bones, spleen and kidneys. The specific location of the enzyme within sinusoidal and bile canalicular membranes could account for its serum elevation in the current study in response to sodium benzoate administration. The ALT enzyme is a strong positive indicator of insulin resistance, diabetes mellitus and obesity which are risk factors for coronary heart disease and is also a sensitive marker of liver damage [23] . Liver enzymes levels are usually raised in acute hepatoxicity, but tend to decrease with prolonged intoxication due to damage to the liver [24] . According to Ranjna et al., [25] , both AST and ALT enzymes are excellent markers of liver damage caused by exposure of liver to toxic substances. However, ALT is more specific liver enzyme for diagnostic use when the integrity of the hepatocellular membrane is compromised [23] . The increased transaminase levels of test rats against the control as observed in the present study could be linked to consumption of sodium benzoate. It was mentioned that the release of abnormally high levels of specific tissue enzymes into blood stream is dependent on both the degree and the type of damage exerted by the toxic compound administration. For the electrolytes, the observe increase in the groups could be an effect on their pumps which can be linked to sodium benzoate administration. This may interfere with these electrolytes in several metabolic pathways leading to increase in their levels in the serum [26].
CONCLUSION AND RECOMMENDA-TION
The main aim of this research was to determine the toxicology effect of the oral administration of sodium benzoate. From the result obtained from the experimental duration it can be observed that sodium benzoate at the varying concentrations, significantly raised serum liver marker enzyme activity and electrolyte levels. The significant changes obtained in some of the measured parameters following oral administration of sodium benzoate points to the need for caution on usage and in the interpretation of blood chemistry data of blood samples, especially for samples drawn from individuals who may have consumed sodium benzoate containing foods before sample collection.
Further studies can be carried to determine its possible toxicology effect on longer periods of administration.
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